Recall -- Firm Press Release
FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.
Purity First Health Products, Inc. Issues Nationwide Recall of Specific Lots of Healthy Life Chemistry B-50, Multi-Mineral and Vitamin C Products: Due to a Potential Health Risk
FOR IMMEDIATE RELEASE - July 31, 2013 - East Northport, New York, Purity First Health Products, Inc. is voluntarily recalling two lots of Healthy Life Chemistry B-50 (100 capsules), one lot of Healthy Life Chemistry Multi-Mineral (200 capsules) and all lot numbers for Healthy Life Chemistry Vitamin C (200 capsules) to the consumer/user level. The B-50 capsules were tested by the U.S. Food and Drug Administration and have been found to contain Methasterone (schedule III controlled substance) and Dimethazine. The Multi-Mineral and Vitamin C capsules appear to indicate the presence of Dimethyltestosterone.
Risk Statement: The contaminated B-50, Multi-Mineral and Vitamin C capsules potentially could result in the following adverse events: liver injury, increased blood lipid levels, increased risk of heart attack and stroke, masculinization of women, shrinkage of the testicles, breast enlargement, infertility in males, and short stature in children. Not to mention fatigue, muscle cramping, and myalgia. The following products are marketed as Dietary Supplements and are packaged in white plastic bottles:
- B-50, 100 capsule bottles, lot numbers F03Q and C02R
- Multi-Mineral, 200 capsule bottles, lot number 12-829
- Vitamin C, 200 capsule bottles, lot number E03Q
Products were distributed Nationwide via the internet, retail and through retail stores between July 2012 thru June 2013.
Immediately discontinue the use of this product and return it to the place of purchase. Consumers with questions should contact Purity First Monday through Friday from 10:00 am to 5:30 pm Eastern Standard Time.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Online: http://www.fda.gov/MedWatch/report.htm
- Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at:
http://www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
- Fax: 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S . Food and Drug Administration.